Plastic Fittings and Tubing for Pharmaceutical and Medical Market - By Product Type, Materials, End Use, Distribution Channel Analysis, Share, Growth Forecast, 2024 - 2032

Plastic Fittings and Tubing for Pharmaceutical and Medical Market Size

The global plastic fittings and tubing for pharmaceutical and medical market size was valued at USD 7.17 billion in 2023 and is estimated to grow at a CAGR of over 6.1% from 2024 to 2032. The demand of disposable medical devices is a key driver for the global market of plastic fittings and tubing for Pharmaceuticals and Medicine.
 

Infection control and cross-contamination are making healthcare facilities lean towards single-use medical devices. IV sets, catheters, drug delivery systems do utilize plastic fittings and tubing that can provide feasible, safe and sterile solutions to reduce patient risk. This is also encouraging because of the new investments in hospital infrastructure and expansion of healthcare services around the world, enhancing the demand for cost-effective and high-quality plastic components with proper hygiene precautions.
 

Also, expansion of biopharmaceuticals is a factor propelling the global demand for plastic fittings and tubing in plastic biopharmaceuticals. Growth in this biopharmaceuticals sector is focusing on complex biologics, vaccines, and personalized medicines drives up the demand for sterile, contamination-free fluid handling systems. Fittings and tubing are vital for keeping non-sterile environments during drug making and transfer. They offer flexibility and high chemical resistance and are usually single-use applications. Furthermore, as the biopharmaceutical production is geared towards meeting heightened global healthcare expectations, there is an increasing need for stringent quality plastic materials, which contributes towards market innovation and expansion.
 

Plastic Fittings and Tubing for Pharmaceutical and Medical Market Trends

The rising global concern regarding the need to protect the environment has led to the gradual use of non-traditional materials for manufacturing fittings and tubing within the medical and pharmaceutical plastics market. There is also an increase in health regulations which require the care of safe alternatives to materials that are harmful to both patients and the surroundings. Typical plastic materials like PVC and DEHP are now being scrutinized for their harmful effects on health and the environment.
 

Safer materials that are more ecologically and biologically friendly are starting to be passed as acceptable by manufacturers. Innovations such as phthalate-free, biodegradable, and recyclable materials are emerging. This trend will help meet the increasing needs for eco-friendly medical devices by healthcare providers and patients as well as further lower the carbon footprint of the industry. This shift in bending the rules of delivery medical devices and tightening the rules on the environment improves the perception of the plastic medical device industry and allows the use of fittings and tubing in medicine.
 

Plastic Fittings and Tubing for Pharmaceutical and Medical Market Analysis

The medical industry is quite highly regulated, which contributes to the problems faced by suppliers of plastic fittings and tubing for pharmaceutical and medical services. These products are a need in the medical sectors since they need to meet stringent criteria for performance, safety, and effectiveness.
 

In the United States, QSR rules dictate that the manufacturer's quality systems be only the most stringent. So too in the European Union. These rules state that design, production, assembly, testing, and even labeling of the medical devices are regulated. According to the Advanced Medical Technology Association (AdvaMed), these guidelines are constructed so that quality in the medical devices manufacturing is never compromised. These rules are necessary. Domestic companies must also follow the regulations in order not to lose reputation, market value, and credibility in the long run.
 

• The global plastic fittings and tubing for pharmaceutical and medical market by product type is segmented as fittings and tubing. The plastic tubing segment is anticipated to generate USD 4.01 billion in revenues and is expected to reach around USD 6.86 billion in the forecasted period. In the plastic fittings and tubing for the medical and pharma sector, plastic tubing comes first in the product ranking. It is critical to numerous applications, including fluid transfer for drug delivery through IV systems or in diagnostic devices. Medical-grade plastic tubing is essential for reliable and hygienic fluid management.
   
• It is for these reasons that the world is striving to switch to advanced technologies, with one being the use of single-use medical devices and systems. Single-use systems in healthcare enable greater infection control. These include single-use plastic syringes, pumps, valves, and many more. As the biopharmaceutical industry grows, so does its need for more infection control systems and devices. Most of these components or systems are used in IV therapy fluid management, such as pumping, injection, drug infusion, and diagnosis. For these reasons, the healthcare industry is turning to plastic tubing to aid with the management of fluids safely and efficiently, making it a leading product in the healthcare market.
   

• By end use the global plastic fittings and tubing for pharmaceutical and medical market is segmented as hospitals and clinics, pharmaceutical manufacturers, Biotechnology companies, Research laboratories and medical device manufacturers. The hospitals and clinics have emerged as the dominant segment, accounting for a market share of approximately 36% in the year 2023, and it is projected to expand at 6.4% during these periods of forecast.
   
• The end-use segments are appealing to the improvement of global plastic fittings and tubing for pharmaceutical and medical purposes. Untreated hygiene conditions call for hospitals and clinics to use massive amounts of plastic tubing and ends to minimize the threat of infections.
   
• This accounts for the rapid growth in demand for single-use and readily disposable medical components. A lot of focus goes into maintaining cleanliness and infection-free environments while treating fluids using disposable plastic parts for intravenous therapies, drug infusions, and even diagnostic procedures. As hygiene conditions are increased, the biotechnology plastic parts reliability is increased along with their economic feasibility increasing as the growth of healthcare facilities around the globe advances. This persistent high requirement strengthens hospitals and clinics as the prime market growth impetus.
   

• North America plastic fittings and tubing for pharmaceutical and medical market holds a dominant geographical segment in revenue of medical and pharmaceutical plastic tubing and fittings: the US is estimated to have 2.45 billion dollars in 2023 and develop at a pace of more than 6.6% until 2032. The advanced healthcare infrastructure in the US makes it easier to soar in this industry due to clinics, hospitals, and specialized medical centers. This causes a strain towards the demand market for most of the medical equipment plastic tubing and fittings.
   

North America: The market for drug-related and medical plastic tubes and their fittings is dominated by the United States, which controls 89% of the North America share, along with single-use medical devices which are set to boost the growth rate to 6.6% every year, changing this sector positively till 2032.
 

Canada, on the other hand, increased their market by 6.2% in 2023, making them the second most investable market after the US. The increase in biotechnology and research institutes needing ultra-modern medical technologies remains the basic reason for this increase since 1.5-inch ball valves are high-quality plastic fittings and tubing.
 

Europe: Europe fittings and tubing for pharmaceutical and medical market is set to expect a sustained performance as they tend to accomplish the projected 6.1% due to global competition from the other three tier 1 countries. The United Kingdom, Germany, and France account for 28% share on the global stage in plastic fittings and tubing for skyscrapers.
 

Germany accounted for a 33% share of the market in 2023. There is a strong focus on the market of eco-friendly plastic materials for medical supplies, with innovations driven by an increase in environmental awareness. Strict guidelines such as the Medical Device Regulation (MDR) and In-vitro Diagnostic Regulation (IVDR) create high barriers for entrance, thereby enabling players to sustain growth of approximately 6.6% for Germany.
 

Asia Pacific: China held a 37% share of the Asia Pacific market for plastic fittings and tubing targeted towards pharmaceutical and medical purposes in 2023, which positions them at the front of the competition. From 2024 to 2032, this share is expected to grow at a CAGR of 6.3%. Emerging urban regions are propelling a growing healthcare sector complemented with inexpensive manufacturing, which is the main driver for this growth. Increasing government expenditure on health supply attracts both foreign and local manufacturers, which helps solidify China as a key market player.
 

Plastic Fittings and Tubing for Pharmaceutical and Medical Market Share

Parker Hannifin, Freudenberg Medical, Nordson, Trelleborg, Smiths Medical together hold a market share of approximately 10-15% in the Plastic Fittings and Tubing for Pharma and Medical segment. Due to the stiff competition, manufacturers are focusing on improving the performance parameters of elastomeric materials, polymers, and silicone.
 

They will be developing high-performance materials to enhance their ability to achieve the tough requirements of the pharmaceutical and medical technology industries, which will expand their market growth and ensure long growth. These advanced materials must be biocompatible, durable, and chemical resistant in order for drug delivery, fluid management, and other medical devices to function effectively.
 

Plastic Fittings and Tubing for Pharmaceutical and Medical Market Companies

Major players operating in the global plastic fittings and tubing industry are:

• AP Extrusion
• Atlas Copco
• Eldon James
• Freudenberg Medical
• Navtar
• New Age Industries
• Nordson
• Parker Hannifin
• Polymer Solutions
• Qosina
• Raumedic
• Saint-Gobain Performance Plastics
• Smiths Medical
• Tekni-Plex
• Trelleborg
   

Plastic Fittings and Tubing for Pharmaceutical and Medical  Industry News

• In August 2024, Nordson Corporation completed its purchase of Atrion Corporation, a company specializing in medical infusion fluid delivery and cardiovascular technologies. This acquisition enables Nordson to offer specialized parts for various medical infusion systems where precise and dependable fluid transfer is vital.
   
• In the Interphex show, the Eldon James Corporation launched the Series Lock XGen genderless connector in April 2024. The XGen series lock is designed with a spring-free fluidics pathway, which allows better volumetric flow at lower pressure. Such technology advancement is supporting the bioprocessing sector tremendously, as it provides a more structured, adaptable, and dependable means of connecting devices and making processes.
   

This global plastic fittings and tubing for pharmaceutical and medical market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) & volume (Thousand Units) from 2021 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Fittings
  • Connectors
  • Adapters
  • Valves
  • Luer fittings
  • Quick-connect fittings
  • Barbed fittings
  • Others
• Tubing
  • Single-lumen tubing
  • Multi-lumen tubing
  • Corrugated tubing
  • Braided tubing
  • Coiled tubing
  • Others

Market, By Materials

• Polyvinyl chloride (PVC)
• Polyethylene (PE)
• Polypropylene (PP)
• PTFE
• Silicone
• Thermoplastic elastomers (TPE)
• Others (nylon, thermoplastic polyurethane, etc.)

Market, By End Use

• Hospitals and clinics
• Pharmaceutical manufacturers
• Biotechnology companies
• Research laboratories
• Medical device manufacturers

Market, By Distribution Channel

• Direct
• Indirect

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • UAE
  • Saudi Arabia
  • South Africa